Here are seven things to know:
1. The company’s total revenues for the quarter ended Sept. 30, were $11.6 million as compared to $2.2 million for the same period last year.
2. Total revenues for the first three quarters of 2015 were $32.1 million. Comparatively, total revenues in the first three quarters of 2014 were $6.2 million.
3. Revenues from anesthesia services were $9.1 million in the quarter, while revenues from product sales were $2.4 million.
4. Total adjusted operating expenses were $5.7 million, an increase of $4.2 million from the third quarter of 2014.
5. Operating EBITDA attributable to shareholders of the company for the quarter was $5.7 million, an increase of $5.03 million over Q3 2014.
6. Operating EBITDA attributable to shareholders for the year ended Sept. 30, 2015 was $16.6 million, an increase of $14.6 million from the comparable period last year.
7. The increases in EBITDA are primarily a reflection of CRH Medical’s newly acquired anesthesia service providers offset by a net increase in product and corporate operating expenses.
More articles on GI/endoscopy:
The biggest challenges for GI in 2016: 3 gastroenterologists weigh in
3 top risk factors for failed fecal transplant
Lovelace Medical Group adds Dr. Julie Farrer: 3 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
